Ellex raises funds to advance eye diagnostic tech
Australia | News | By BioSpectrum Bureau | 0 Comment | 19 Sep, 2013
Singapore: Australia-based Ellex Medical Lasers, medical technology developers for the diagnosis and treatment of eye di...Read more
Sanofi launches JE vaccine in Australia
Australia | News | By BioSpectrum Bureau | 0 Comment | 10 Dec, 2012
Singapore: Sanofi Pasteur, the vaccines division of Sanofi, has launched IMOJEV vaccine against Japanese encephalitis (J...Read more
Alchemia issues shares, raises $10 mn
Australia | News | By BioSpectrum Bureau | 0 Comment | 11 Mar, 2013
Singapore: Australian-based drug discovery and development company Alchemia has raised $10.44 million (A$10.2 million) ...Read more
Aquavit, Uniquest sign medtech MoU
Australia | News | By BioSpectrum Bureau | 0 Comment | 10 Oct, 2012
Singapore: Aquavit Life Sciences, a wholly owned subsidiary of Aquavit Pharmaceuticals, signed a memorandum of understa...Read more
Challenges teach you a lot about yourself: Julie Philips
Australia | Influencers | By BioSpectrum Bureau | 0 Comment | 07 Mar, 2013
"Obstacles are those frightful things you see when you take your eyes off your goal." — Henry Ford I started my ...Read more
BioSpectrum Asia launches 5th CRO survey
Australia | News | By BioSpectrum Bureau | 0 Comment | 30 Jul, 2013
Singapore: After four consecutive successful annual surveys on the developments in the clinical research industry, BioSp...Read more
Antibody R&D: What APAC firms are working on?
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 03 Oct, 2012
Over the years, some of the Asian companies have made significant breakthroughs in antibody research and are exploring f...Read more
Imugene expands scientific advisory board
Australia | Influencers | By BioSpectrum Bureau | 3 Comment | 20 Jan, 2014
Singapore: Australian biopharmaceutical company Imugene has appointed Dr Christoph Zielinski and Dr Ursula Wiedermann to...Read more
LCT, Otsuka to co-develop NTCELL for Parkinson's
Australia | News | By BioSpectrum Bureau | 0 Comment | 17 Dec, 2012
Singapore: Living Cell Technologies have signed an agreement with Otsuka Pharmaceutical Factory to co-develop NTCELL for...Read more
CSL files biologics license plea with FDA
Australia | Regulatory | By BioSpectrum Bureau | 3 Comment | 30 May, 2012
Singapore: The US Food and Drug Administration (FDA) has accepted Australia-based CSL Behring's biologics license applic...Read more
Victoria launches 'Code of Best Practice' for biotech directors
Australia | News | By BioSpectrum Bureau | 0 Comment | 29 Oct, 2013
Singapore: Victorian Minister for Technology, Mr. Gordon Rich-Phillips, has launched a Guide for Life Science Company Di...Read more
MNCs boost Asia biologics industry
Australia | News | By BioSpectrum Bureau | 0 Comment | 07 Mar, 2012
Entry of multinational companies has been a big boost to Asia's position in biologics manufacturing, especially with cGM...Read more
Genetic test predicts Autism risk
Australia | News | By BioSpectrum Bureau | 0 Comment | 12 Sep, 2012
Singapore: A team of Australian researchers, led by University of Melbourne has developed a genetic test that is able to...Read more
LCT conducts first implant of regenerative therapy
Australia | News | By BioSpectrum Bureau | 0 Comment | 20 Sep, 2013
Singapore: Australia-based Living Cell Technologies (LCT) has implanted regenerative cell therapy NTCELL, a treatment fo...Read more
Gilead leukemia study gets complete response
Australia | News | By BioSpectrum Bureau | 0 Comment | 16 May, 2013
Singapore: Gilead Sciences' phase II study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational, ...Read more
Fund freeze by Australia govt worries biotech
Australia | News | By BioSpectrum Bureau | 0 Comment | 20 Sep, 2012
Singapore: AusBiotech calls on the Federal Government to provide some certainty to the innovation sector as support pro...Read more
Projects under Indo-Australia Biotechnology Fund
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 18 May, 2012
...Read more
FDA accepts resubmission of Moxduo NDA by QRxPharma
Australia | News | By BioSpectrum Bureau | 0 Comment | 15 Mar, 2013
Singapore: The US Food and Drug Administration (FDA) has set August 26, 2013, as the date for action on QRxPharma's res...Read more